Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-03

FDA Tentative Approval: CARBIDOPA AND LEVODOPA — Original Application (BIOCON PHARMA LIMITED)

View source ↗

Summary

FDA tentative approval for a generic CARBIDOPA AND LEVODOPA product (BIOCON PHARMA LIMITED) under ANDA 220119.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG TA for CARBIDOPA AND LEVODOPA (CARBIDOPA,LEVODOPA)